About Troy Wilson
Troy Wilson is an executive chairman at Caspian Therapeutics.
Form D filings also name Troy Wilson as a director at Montara Therapeutics.
Troy Wilson reports to the SEC as a director, officer or major shareholder of 5 public companies, including Puma Biotechnology (PBYI), Kura Oncology (KURA) and Atrium Therapeutics (RNA).
Troy Wilson first appears on SEC filings in 2013.
Experience
This experience comes from Troy Wilson's profile and from SEC filings. For roles taken from filings, the years are when the filings name Troy Wilson in the role, so the role may have started earlier or lasted longer.
Caspian Therapeutics, Inc. Current
Executive Chairman of the Board and Co-Founder
2026 – Present · San Diego, CA
Develops drug candidates for people with diabetes and other metabolic diseases.
AI
Atrium Therapeutics, Inc. Current
Director
2026 – Present · Public company (RNA)
Montara Therapeutics, Inc. Current
Chairman of the Board of Directors
2025 – Present · San Francisco, CA
CB
Cartography Biosciences Current
Chairman of the Board of Directors
2024 – Present
KI
Kura Oncology, Inc. Current
President and CEO, director
President, Chief Executive Officer and Chairman of the Board (2014 – Present)
2014 – Present · Public company (KURA)
PI
Puma Biotechnology, Inc. Current
Member Board of Directors
2013 – Present · Public company (PBYI)
AL
Araxes Pharma, LLC Current
Sole Managing Member
2012 – Present
AI
Avidity Biosciences, Inc.
Chair of the Board of Directors
2013 – 2026 · Public company (RNAM)
WB
Wellspring Biosciences
Executive Chairman
2012 – 2023
ZC
Zosano Pharma Corp
Director
2015 – 2019 · Public company (ZSAN)
IN
Intellikine
President, CEO and Co-Founder
2007 – 2012
WT
Wildcat Discovery Technologies
President and Co-Founder
2006 – 2007
AM
Ambrx
Chief Business Officer and Co-Founder
2003 – 2006
GN
GNF
Vice President, Business Development and General Counsel
2000 – 2003
Key Colleagues at Startups
The people Troy Wilson works with at each company, as listed on that company's latest Form D.
Caspian Therapeutics, Inc. · Form D, Sep 23, 2026
RS
Robert Spencer
President and Chief Operating Officer
SL
Spike Loy
Director
Montara Therapeutics, Inc. · Form D, Mar 13, 2025
ML
Max Lebovitz
Executive officer
SS
Seth Stratton
Director
ZH
Zachary Hill
Executive officer
RR
Rishi Rakhit
Executive officer
RC
Randall Chin
Executive officer
DL
Dirk Langdorf
Director
NH
Nicholas Hertz
President & CEO, director